Xiidra, a prescription eye drop used to treat dry eye disease, has a list price of $587.12 for a 30-day supply, according to GoodRx. However, the actual out-of-pocket cost for individuals without insurance can vary significantly.
How Much Do Xiidra Savings Cards Cost?
Pharmaceutical companies often provide savings cards that can lower the out-of-pocket expense for eligible patients. For commercially insured patients with Xiidra, the manufacturer offers a savings program that can reduce the cost to as little as $10 for a 30-day supply. Eligibility and program details are subject to change and typically require a valid prescription.
What Are the Alternatives to Xiidra?
Patients seeking alternatives to Xiidra might consider other prescription eye drops or over-the-counter options. Prescription alternatives may include medications like Restasis or Cequa, which work differently to manage dry eye symptoms. Over-the-counter artificial tears are also widely available and can provide temporary relief for many individuals. The effectiveness and cost of these alternatives can differ from Xiidra.
When Does Xiidra's Patent Expire?
Information regarding Xiidra's patent expiration is available through resources like DrugPatentWatch.com. Understanding patent exclusivity is crucial as it can indicate when generic versions of a medication may become available, potentially leading to lower prices [1].
How Can Patients Afford Xiidra?
Beyond manufacturer savings programs, patients may explore several avenues to manage the cost of Xiidra. Patient assistance programs (PAPs) offered by pharmaceutical companies can provide free or low-cost medication to eligible individuals who lack adequate insurance. Additionally, some pharmacies may offer discount programs or comparisons for prescription medications. Exploring these options can significantly reduce the financial burden of obtaining Xiidra.
What Side Effects Are Associated with Xiidra?
Common side effects reported with Xiidra use include eye irritation, stinging or burning sensations, pain in the eyes, redness, and blurred vision. Less common but more serious side effects can also occur. Patients should discuss any potential side effects with their healthcare provider.
Who Manufactures Xiidra?
Xiidra is manufactured by Takeda Pharmaceuticals U.S.A., Inc. [2].
*
**Sources
1. DrugPatentWatch.com
2. Takeda Pharmaceuticals U.S.A., Inc.